---
figid: PMC6030166__41419_2018_761_Fig6_HTML
figtitle: Combined network analysis of metabolites and lipids
organisms:
- Homo sapiens
- Rattus norvegicus
- Bos taurus
pmcid: PMC6030166
filename: 41419_2018_761_Fig6_HTML.jpg
figlink: /pmc/articles/PMC6030166/figure/Fig6/
number: F6
caption: 'Combined network analysis of metabolites and lipids. Data from both the
  metabolomics and the lipidomics analyses were combined. Samples used were from (lovastatin + docetaxel)-treated
  cells for 36 h. The shapes and colors were as follows: ovals for metabolites and
  rectangles for lipids; from yellow to dark orange, more and more up-regulated, from
  light blue to dark blue, more and more down-regulated'
papertitle: Consequences of blunting the mevalonate pathway in cancer identified by
  a pluri-omics approach.
reftext: Sophie Goulitquer, et al. Cell Death Dis. 2018 Jul;9(7):745.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7271361
figid_alias: PMC6030166__F6
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Bos taurus
redirect_from: /figures/PMC6030166__F6
ndex: 82850a9a-df31-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6030166__41419_2018_761_Fig6_HTML.html
  '@type': Dataset
  description: 'Combined network analysis of metabolites and lipids. Data from both
    the metabolomics and the lipidomics analyses were combined. Samples used were
    from (lovastatin + docetaxel)-treated cells for 36 h. The shapes and colors were
    as follows: ovals for metabolites and rectangles for lipids; from yellow to dark
    orange, more and more up-regulated, from light blue to dark blue, more and more
    down-regulated'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCL2L11
  - MYC
  - PTGS2
  - SGMS2
  - LCAT
  - APOE
  - CES2
  - CES1
  - PYCR2
  - PYCR3
  - GBA1
  - GBA1LP
  - HLA-B
  - HLA-C
  - AIMP2
  - PSMA4
  - UBB
  - TTL
  - NARS1
  - IMPA2
  - FOLH1
  - ACD
  - AIMP1
  - FARSB
  - TARS1
  - PIK3CA
  - UBC
  - RPS27A
  - GFPT1
  - MARS1
  - SLA2
  - AARS2
  - MAT1A
  - KYAT1
  - PYCR1
  - ASNS
  - PPIA
  - PAICS
  - ATAD2
  - ABAT
  - CIC
  - SLC25A1
  - ACLY
  - GAD1
  - NAGS
  - SLC2A1
  - GOT2
  - GCLM
  - TK1
  - SDHA
  - FAH
  - FANCA
  - FAHD1
  - PPP1CB
  - H3C1
  - HMOX1
  - GOT1
  - GOLT1B
  - GOLT1A
  - GCLC
  - SLC25A12
  - APEH
  - Bcl2l11
  - Myc
  - Ptgs2
  - Sgms2
  - Lcat
  - Apoe
  - Ces2
  - Ces2c
  - Ces2h
  - Pycr2
  - Pycr3
  - Gba1
  - Aimp2
  - Psma4
  - Ubb
  - Uba52
  - Ttl
  - Nars1
  - Impa2
  - Folh1
  - Acd
  - Aimp1
  - Farsb
  - Tars1
  - Pik3ca
  - Ubc
  - Gfpt1
  - Mars1
  - Aars2
  - Mat1a
  - Kyat1
  - Pycr1
  - Asns
  - Ppia
  - Paics
  - Atad2
  - Abat
  - Cic
  - Slc25a1
  - Acly
  - Gad1
  - Nags
  - Slc2a1
  - Got2
  - Gclm
  - Tk1
  - Sdha
  - Fah
  - Fahd1
  - Ppp1cb
  - Hmox1
  - Got1
  - Gclc
  - Slc25a12
  - UBA52
  - FOLH1B
  - Ceramide
  - 5-Aminovaleric acid
  - Sphingamyelin
  - L-Threonine
  - D-Glucose
  - Lysine
  - Azelaic acid
  - Asparagine
  - Gutamine
  - Arginine
  - Proline
  - L-Methionin
  - Isoleucine
  - Tyrosine
  - Phenylalanine
  - LHomoserine
  - Aspartate
  - Alanine
  - Ribose
  - Glutamic acid
  - Ribothymidine
  - Omithine
  - Thymidine
  - Beta-Alanine
  - Uric acid
  - Creatinine
---
